Does gabapentin help muscle spasms
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Muscle Spasms: Efficacy and Insights
Gabapentin and Muscle Spasms in Multiple Sclerosis
Gabapentin has been studied for its effectiveness in treating muscle spasms and spasticity in patients with multiple sclerosis (MS). A double-blind, placebo-controlled crossover study involving 15 patients with MS demonstrated that gabapentin significantly improved spasticity and painful muscle cramps. The study used various scales, including the Ashworth Scale and the Visual Faces Scale, to measure outcomes, and found notable improvements in these measures for patients treated with gabapentin at a dose of 400 mg three times daily .
Gabapentin for Spasticity in Spinal Cord Injury
Research has also explored gabapentin's role in managing spasticity in individuals with spinal cord injury (SCI). A study involving six men with SCI used surface electromyography (EMG) to assess spasticity and found that while the group results did not reach statistical significance at the dosage used (400 mg three times daily), individual cases showed marked improvements. Higher doses of gabapentin (up to 3600 mg/day) during an open-label extension phase provided greater control of spasticity . Another study with 25 SCI patients reported an 11% reduction in spasticity as measured by the Ashworth Scale and a 20% reduction in patient-rated spasticity using the Likert Scale, suggesting gabapentin's potential utility in managing spasticity in this population .
Gabapentin's Effectiveness in Upper Motor Neuron Syndrome
A randomized, double-blind, placebo-controlled trial involving 30 patients with upper motor neuron syndrome found that gabapentin significantly improved spasticity as measured by the Ashworth Scale. The study also noted improvements in individual muscle groups affected by spasms, although no significant changes were observed in the range of movement or quality of life measures .
Gabapentin for Hemifacial Spasm
Gabapentin has shown promise in treating hemifacial spasm, a condition characterized by involuntary facial muscle contractions. In a study involving 23 patients, gabapentin significantly reduced spasm frequency in 69.6% of the participants, indicating its efficacy and safety for this condition . Another report of five patients with hemifacial spasm treated with gabapentin (900 to 1600 mg daily) also noted rapid and clear improvement of spasms without significant adverse effects .
Gabapentin in Animal Models
Animal studies have further supported gabapentin's muscle relaxant properties. In experiments with albino rats, gabapentin demonstrated significant muscle relaxation effects comparable to diazepam, a well-known muscle relaxant. These findings suggest that gabapentin could be a viable option for managing muscle spasms and spasticity in clinical settings .
Conclusion
Gabapentin appears to be an effective treatment for muscle spasms and spasticity across various conditions, including multiple sclerosis, spinal cord injury, upper motor neuron syndrome, and hemifacial spasm. While higher doses may provide greater benefits, the drug has shown significant improvements in spasticity and muscle cramps with relatively few adverse effects. Further research, particularly controlled studies with higher doses, is warranted to fully establish gabapentin's efficacy and optimal dosing for these conditions.
Sources and full results
Most relevant research papers on this topic